Syneos Health Inc logo

Syneos Health Inc

€ 48.76 (+1.9%) Sep 29
P/E:
17.73
P/B:
1.45
Market Cap:
€ 4.92B ($ 4.83B)
Enterprise V:
€ 7.98B ($ 7.82B)
Volume:
15.00
Avg Vol (2M):
47.00
Also Trade In:
Volume:
15.00
Market Cap €:
4.92B
Market Cap $:
4.83B
PE Ratio:
17.73
Avg Vol (2-Month):
47.00
Enterprise Value €:
7.98B
Enterprise Value $:
7.82B
PB Ratio:
1.45
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Financials (Next Earnings Date:2022-11-03 Est.)

FRA:8IN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 4,862.017
EPS (TTM) (€) 2.385
Beta 1.35
Volatility % 29.26
14-Day RSI 29.99
14-Day ATR (€) 1.545584
20-Day SMA (€) 54.289
12-1 Month Momentum % -22.62
52-Week Range (€) 47.845 - 89.5
Shares Outstanding (Mil) 102.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Syneos Health Inc Filings

Document Form Filing Date
No Filing Data

Syneos Health Inc Analysis

Share your research